InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2021-11-15 00:00:00 ET · period of report 2021-11-10 · accession 0001209191-21-064519 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-11-15 2021-11-10 WGS Assad Shawn CAO M - OptEx — +10.5K 20.9K +100% —
D 2021-11-15 2021-11-10 WGS Assad Shawn CAO S - Sale+OE $7.87 -3,114 17.8K -15% -$24.5K
D 2021-11-15 2021-11-10 WGS Assad Shawn CAO M - OptEx $0.00 -10.5K 146.4K -7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-11-10 M A 10,457 — 20,914 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration.
2 Common Class A Common Stock 2021-11-10 S D 3,114 $7.87 17,800 D — —
3 Derivative Restricted Stock Unit 2021-11-10 M D 10,457 $0.00 146,408 D — · — to — 10,457 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. (F3) 1/16th of the total shares vested on October 25, 2021 and November 10, 2021, and thereafter vests as to 1/16th of the total shares underlying the award in quarterly installments until fully vested on May 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.